Arrowstreet Capital
EVH icon

Arrowstreet Capital’s Evolent Health EVH Stock Holding History

Arrowstreet Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$163K Buy
+46,765
New +$207K ﹤0.01% 1761
2023
Q2 		– Sell
-194,863
Closed -$6.32M – 1295
2023
Q1 		$6.32M Buy
194,863
+93,501
+92% +$2.96M 0.01% 639
2022
Q4 		$2.85M Sell
101,362
-79,440
-44% -$2.28M ﹤0.01% 786
2022
Q3 		$6.5M Buy
180,802
+155,919
+627% +$5.49M 0.01% 601
2022
Q2 		$764K Buy
+24,883
New +$725K ﹤0.01% 988
2021
Q3 		– Sell
-341,055
Closed -$7.2M – 1667
2021
Q2 		$7.2M Sell
341,055
-452,732
-57% -$9.07M 0.01% 949
2021
Q1 		$16M Sell
793,787
-205,779
-21% -$3.91M 0.02% 677
2020
Q4 		$16M Buy
999,566
+72,875
+8% +$963K 0.02% 680
2020
Q3 		$11.5M Buy
926,691
+71,590
+8% +$842K 0.02% 776
2020
Q2 		$6.09M Buy
+855,101
New +$5.73M 0.01% 975
2019
Q2 		– Sell
-36,871
Closed -$464K – 1477
2019
Q1 		$464K Buy
+36,871
New +$584K ﹤0.01% 1499

Other funds holding EVH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Rubicon Founders
Rubicon Founders Nashville, Tennessee $147M AUM 17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Rock Point Advisors
Rock Point Advisors Burlington, Vermont $402M AUM 17.12% 1-Year Est. Return

Arrowstreet Capital's EVH Position: Q3 2026 in Review

Arrowstreet Capital opened a new position in Evolent Health (EVH) in Q3 2026: 46,765 shares worth $163K. The stake represents ﹤0.01% of the portfolio and ranks #1761 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in EVH as recently as Q1 2023.

Arrowstreet Capital first reported a position in EVH in Q1 2019 and has held it in 11 quarters since. The position peaked at $16M in Q1 2021. 129 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Arrowstreet Capital held 46,765 shares of Evolent Health worth $163K as of Q3 2026.
  • Evolent Health was a new Arrowstreet Capital position in Q3 2026.
  • Evolent Health made up ﹤0.01% of Arrowstreet Capital's portfolio in Q3 2026, its #1761 holding.
  • Arrowstreet Capital first reported a position in Evolent Health in Q1 2019 and has held it in 11 quarters since.
  • Arrowstreet Capital's Evolent Health position peaked at $16M in Q1 2021.
  • 129 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.